"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Current Neuropharmacology 14.8(2016).
Acetylcarnitine levels under physiological and pathological conditions Several studies have shown that long-term use of acetylcarnitine reduces symptoms of chronic fatigue and improves the general condition in patients with chronic fatigue syndrome (Table 1, [79, 81, 142])
Weight loss may be associated with other symptoms, e.g., muscle loss, fatigue, menstrual changes, gallstones, and mood changes
Changes in zinc concentrations beyond the cells ability to coordinate can lead to tumorigenesis, as zinc provides the bioenergetic/ synthetic requirements of malignancy, such as the aberrant expression of zinc transporters and dysregulation of MTs binding proteins
FDA approval dates for these GLP-1 RAs are detailed in Table S3
No harsh chemicals or side effects